News from us and our partners

Tags

Topics

0 results

News
14 March, 2022
Catamaran Bio expands collaboration for CAR-NK cell engineering with the University of Minnesota and secures an exclusive patent license to next generation manufacturing technologies
News
10 March, 2022
RefleXion raises $80 million to broaden cancer treatment options
News
10 March, 2022
Abivax reports promising ABX464 phase 2A one-year maintenance results in rheumatoid arthritis
News
8 March, 2022
Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA
News
1 March, 2022
Noema Pharma appoints Michael Gutch as CFO
News
28 February, 2022
Lucia Faccio comments on the increased interest from investors in the rare diseases space
News
28 February, 2022
Catamaran Bio announces appointment of Michael DeRidder, PhD, as senior vice president, corporate strategy and new product planning
News
24 February, 2022
Women on both sides of the 'pitch call' meet at virtual round table
News
23 February, 2022
"We build them to be great companies," Anne Osdoit tells In Vivo
News
23 February, 2022
Antoine Papiernik discusses Theranos in lively France Culture podcast
News
23 February, 2022
Mnemo Therapeutics names Robert LaCaze as CEO
News
22 February, 2022
EryDel appoints Thomas Sabia as chief commercial officer
News
22 February, 2022
Noema Pharma announces first patient dosed in Phase 2b LibraTN study of mGluR5 inhibitor NOE-101 in trigeminal neuralgia
News
22 February, 2022
Myricx Pharma announces senior team expansion with appointment of CMO and heads of biology and bioinformatics
News
14 February, 2022
Noema Pharma announces FDA Investigational New Drug Authorization for Phase 2b study of trigeminal neuralgia therapy
News
11 February, 2022
ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10

Catamaran Bio expands collaboration for CAR-NK cell engineering with the University of Minnesota and secures an exclusive patent license to next generation manufacturing technologies

RefleXion raises $80 million to broaden cancer treatment options

Abivax reports promising ABX464 phase 2A one-year maintenance results in rheumatoid arthritis

Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA

Noema Pharma appoints Michael Gutch as CFO

Lucia Faccio comments on the increased interest from investors in the rare diseases space

Catamaran Bio announces appointment of Michael DeRidder, PhD, as senior vice president, corporate strategy and new product planning

Women on both sides of the 'pitch call' meet at virtual round table

"We build them to be great companies," Anne Osdoit tells In Vivo

Antoine Papiernik discusses Theranos in lively France Culture podcast

Mnemo Therapeutics names Robert LaCaze as CEO

EryDel appoints Thomas Sabia as chief commercial officer

Noema Pharma announces first patient dosed in Phase 2b LibraTN study of mGluR5 inhibitor NOE-101 in trigeminal neuralgia

Myricx Pharma announces senior team expansion with appointment of CMO and heads of biology and bioinformatics

Noema Pharma announces FDA Investigational New Drug Authorization for Phase 2b study of trigeminal neuralgia therapy

ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10